Le Lézard
Classified in: Health
Subjects: POLITICS, ARTS/ENTERTAINMENT, HEALTH, LIFESTYLE, MISCELLANEOUS

1 in 5 young Canadians struggles with mental health. TVO Today's In Our Heads podcast asks why.


Toronto, Ontario, June 14, 2023 (GLOBE NEWSWIRE) -- Canadian youth are facing an unprecedented mental health crisis. How did we get here and what solutions are available? Premiering today via Apple Podcasts, Spotify, Google Podcasts and elsewhere, TVO Today's In Our Heads podcast is a six-part series that illuminates the causes, challenges and risks of ongoing systemic gaps in mental healthcare. 

"The roots of our current mental health crisis stretch beyond the pandemic, but the acute impacts of the past three years are unlike anything Canadian youth have ever experienced," says John Ferri, VP of Current Affairs and Documentaries at TVO. "In Our Heads untangles what teenagers and young adults are facing right now. The series is compassionate, insightful and, at times, heart-rending. You need to hear this."

With new episodes available weekly on Wednesdays, In Our Heads builds upon the Investigative Journalism Bureau's series Generation Distress, which was published in The Toronto Star and examined mental health challenges for secondary and post-secondary students in Canada and the United States. 

The Generation Distress series found that one in five Canadian youth are part of the mental health crisis. Of the 152 young interviewees who expressed mental health struggles, 90% were suffering from anxiety, 80% were suffering from depression, 62% considered quitting school and 48% contemplated suicide. This data should alarm every Canadian and motivate action on reforms.

In Our Heads is hosted by Tiffany Lam, a journalist and podcast producer at TVO Today. Episodes feature candid conversations with youth, experts and others who have experienced the systemic gaps in mental healthcare. Through researched statistics and informed storytelling, this podcast helps build understanding about how young people are experiencing their lives today. 

Listen to the series trailer and the first episode of TVO Today's In Our Heads wherever you get podcasts. Subscribe, review and share to help others discover the series. 

Background: 

-30-

ABOUT TVO MEDIA EDUCATION GROUP
TVO Media Education Group inspires learning that changes lives and enriches communities. Founded in 1970, we are a globally recognized digital learning organization that engages Ontarians of all ages with inclusive experiences and diverse perspectives. Through video, audio, games, courses, newsletters and articles, we're investing in the transformative potential of education for everyone. Funded primarily by the Province of Ontario, TVO is a registered charity supported by thousands of sponsors and donors. For more information, visit TVO.me, TVO.org and TVOkids.com

Stream TVO on your favourite device.
Sign up to receive TVO media releases by email.

Media contact:
Sean Minogue, TVO
[email protected] 

Social:
Twitter: @TVO 
Facebook: @TVO 
Instagram: @WeAreTVO
YouTube: /TVO



These press releases may also interest you

at 03:05
Kindeva Drug Delivery (Kindeva), a global leader in drug-device combination products, today announced its investment in a second manufacturing line for the production of pressurized metered-dose inhaler (pMDI) products containing low-GWP (Global...

at 03:05
Lantern Pharma Inc. , a leading artificial intelligence (AI) oncology drug discovery and development company, today announced a strategic AI-driven collaboration with French biotechnology company, Oregon Therapeutics to optimize the development of...

at 03:00
Patients with spinal cord injury (SCI) could benefit from future treatment to repair nerve connections using red and near-infrared light....

at 03:00
A recent global survey conducted by the World Lupus Federation reported that 91% of survey respondents were taking or have taken oral steroids to treat their lupus. Over 7,700 people living with lupus from more than 100 countries participated in the...

at 02:11
Calliditas Therapeutics AB ("Calliditas") today announced data from the proof-of-concept Phase 2 trial evaluating setanaxib, its lead NOX enzyme inhibitor, in combination with pembrolizumab, in patients with squamous cell carcinoma of the head and...

at 00:01
The Novo Nordisk Foundation, Wellcome, and the Bill & Melinda Gates Foundation announced a new partnership to support critical scientific research and development (R&D) for global health. The partnership is focused on supporting science and...



News published on and distributed by: